AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca astraZeneca PLC Common Stock / ADRs held by US 401(k) Plan ($) ($)
Form 11-K Fair Value Hierarchy Note
Latest, FY2025
179,582,037
Period ended Dec 31, 2025
Change on a year earlier
+28.5%
139,748,329 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | AstraZeneca PLC Common Stock / ADRs held by US 401(k) Plan ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 179,582,037 | +28.5% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2024 | Dec 31, 2024 | 139,748,329 | -11.8% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2023 | Dec 31, 2023 | 158,431,850 | -5.2% | Form 11-K FY2024 (AstraZeneca US 401(k) Plan) ↗ |
| FY2022 | Dec 31, 2022 | 167,148,357 | +10.5% | Form 11-K FY2023 (AstraZeneca US 401(k) Plan) ↗ |
| FY2021 | Dec 31, 2021 | 151,257,134 | +7.9% | Form 11-K FY2022 (AstraZeneca US 401(k) Plan) ↗ |
| FY2020 | Dec 31, 2020 | 140,210,302 | -8.6% | Form 11-K FY2021 (AstraZeneca US 401(k) Plan) ↗ |
| FY2019 | Dec 31, 2019 | 153,415,281 | – | Form 11-K FY2020 (AstraZeneca US 401(k) Plan) ↗ |
Cite this data
StockData. (2026). AstraZeneca AstraZeneca PLC Common Stock / ADRs held by US 401(k) Plan ($) ($), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/plan11k_fv_azn_adrs
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.